Cerus (CERS) Net Margin Growth (1y) (2011 - 2026)
Cerus (CERS) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -314.00 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 123.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 94.00 |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1,132.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 656.00 |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -430.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 201.00 |
| 10 | Cerus | 600.87 Mn | 520.44 Mn | 27.89 Mn | 1,478.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,478.00 |
| Dec 31, 2025 | 128.00 |
| Sep 30, 2025 | 42,129.00 |
| Jun 30, 2025 | -102,560.00 |
| Mar 31, 2025 | 741.00 |
| Dec 31, 2024 | -217.00 |
| Sep 30, 2024 | 374,188.00 |
| Jun 30, 2024 | 1,512.00 |
| Mar 31, 2024 | 8,624.00 |
| Dec 31, 2023 | 695.00 |
| Sep 30, 2023 | -403,760.00 |
| Jun 30, 2023 | -1,384.00 |
| Mar 31, 2023 | -2,851.00 |
| Dec 31, 2022 | -992.00 |
| Sep 30, 2022 | 8,250.00 |
| Jun 30, 2022 | 8,440.00 |
| Mar 31, 2022 | 9,765.00 |
| Dec 31, 2021 | 572.00 |
| Sep 30, 2021 | 209,070.00 |
| Jun 30, 2021 | -205.00 |